The most frequent mutations of advanced HCC were TERT promoter (51%), TP53 (32%), CTNNB1 (17%), PTEN (8%), AXIN1, ARID2, KMT2D, and TSC2 (each 6%) [46]. This evidence concerns the gene TP53 and hepatocellular carcinoma.